NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
Abstract Background NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants ar...
Guardado en:
Autores principales: | Anna Misya’il Abdul Rashid, Mohamad Syafeeq Faeez Md Noh, Abdul Hanif Khan Yusof Khan, Wei Chao Loh, Janudin Baharin, Azliza Ibrahim, Liyana Najwa Inche Mat, Wan Aliaa Wan Sulaiman, Fan Kee Hoo, Fazah Akhtar Hanapiah, Hamidon Basri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SpringerOpen
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e2912eb01e540368284ee5b4ff77d01 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials.
por: Nabil Izzaatie Mohamad Safiai, et al.
Publicado: (2021) -
Acta Nº901
por: Banco Central de Chile
Publicado: (2019) -
Sustained-release nanoART formulation for the treatment of neuroAIDS
por: Jayant RD, et al.
Publicado: (2015) -
Hot Deformation Behavior and Processing Map of GH901 Superalloy
por: Rui Ma, et al.
Publicado: (2021) -
MLC601 in vascular dementia: an efficacy and safety pilot study
por: Pakdaman H, et al.
Publicado: (2017)